Results 21 to 30 of about 79,822 (211)

Prevention of Antigen-Induced Bronchial Hyperreactivity and Airway Inflammation in Sensitized Guinea-Pigs by Tacrolimus

open access: yesMediators of Inflammation, 1999
We examined the effect of the immunosuppressive agent, tacrolimus (FK506), on antigen-induced bronchial hyperreactivity to acetylcholine and leukocyte infiltration into the airways of ovalbumin-challenged guinea-pigs.
J. R. Lapa e Silva   +5 more
doaj   +1 more source

Epithelial barrier dysfunction in bronchial asthma

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022
The pathogenesis of bronchial asthma is based on chronic inflammation as a response to etiological factors. It causes bron-chial hyperreactivity, remodeling of the respiratory tract and hypersecretion of mucus.
R. N. Khramova   +2 more
doaj   +1 more source

Influence of sensitization and allergen provocation procedures on the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs

open access: yesMediators of Inflammation, 1995
The effects of different sensitization and allergen provocation regimens on the development of allergen-induced bronchial hyperreactivity (BHR) to histamine were investigated in conscious, unrestrained guinea-pigs.
R. E. Santing   +4 more
doaj   +1 more source

Airway obstruction and bronchial reactivity from age 1 month until 13 years in children with asthma: A prospective birth cohort study.

open access: yesPLoS Medicine, 2019
BackgroundStudies have shown that airway obstruction and increased bronchial reactivity are present in early life in children developing asthma, which challenges the dogma that airway inflammation leads to low lung function. Further studies are needed to
Henrik Wegener Hallas   +6 more
doaj   +1 more source

Modulation of pulmonary allergic responses by mucosal cytokine–gene transfer* A summary of this review was presented at the Spring Meeting of the 8th Japanese Congress of Allergology. Originally published in the Journal of Immunology 1996; 157: 3216–19. Copyright 1996. The American Association of Immunologists. This article can not be reproduced in an electronic form.

open access: yesAllergology International, 1997
Recent clinical and experimental animal studies have provided evidence for a pivotal role of T lymphocytes and Th2 cytokines in the development of allergic inflammatory responses and airway hyperreactivity.
Shau-Ku Huang, Xiu-Min Li
doaj   +1 more source

FEATURES OF TRANSFORMATIONS OF RED BLOOD CELLS IN CHILDREN WITH BRONCHIAL ASTHMA

open access: yesМедицинская иммунология, 2017
Increase prevalence of bronchial asthma (BA) is noted recently. That’s why its treatment remains an urgent problem in allergology. Along with congenital atopy, a significant role in formation and development of a disease is given to hyperreactivity of ...
E. N. Suprun   +8 more
doaj   +1 more source

Secondhand Smoke Exposure Causes Bronchial Hyperreactivity via Transcriptionally Upregulated Endothelin and 5-hydroxytryptamine 2A Receptors. [PDF]

open access: yes, 2012
Cigarette smoke exposure is strongly associated with airway hyperreactivity (AHR) which is the main characteristic seen in asthma. The intracellular MAPK signaling pathways are suggested to be associated with the airway damage to the AHR.
Edvinsson, Lars   +19 more
core   +2 more sources

Associations among high altitude, allergic rhinitis, and bronchial hyperreactivity

open access: yes, 2017
Allergic respiratory diseases are common public health problem. Although several treatment options, some of patients cannot manage to get satisfactory recovery.
Erdim, Ibrahim   +3 more
core   +1 more source

Perinatal respiratory infections and long term consequences

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2015
Respiratory syncytial virus (RSV) is the most important pathogen in the etiology of respiratory infections in early life. 50% of children are affected by RSV within the first year of age, and almost all children become infected within two years. Numerous
Luciana Indinnimeo, Valentina De Vittori
doaj   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy